On July 26 and 27, 2021, the National Cancer Policy Forum convened a virtual workshop that examined changes in cancer research and care that occurred in response to the COVID-19 pandemic, and considered lessons learned from that experience in order to improve the conduct of cancer clinical trials and the delivery of high-quality cancer care in the post-pandemic era, with an emphasis on health equity.
Speakers
Kald Abdallah, Bristol Myers Squibb
Sundeep Agrawal, Food and Drug Administration
Derek Angus, University of Pittsburgh Medical Center
Dietmar P. Berger, Sanofi (representing TransCelerate)
Shonta Chambers, Patient Advocate Foundation
Loretta Christensen, Indian Health Service
William Dahut, National Cancer Institute
James H. Doroshow, National Cancer Institute
Lee Fleisher, Centers for Medicare & Medicaid Services
Shelley Fuld Nasso, National Coalition for Cancer Survivorship
Elizabeth Garrett-Mayer, American Society of Clinical Oncology
Randall N. Hyer, Moderna Inc.
Paul Jacobsen, National Cancer Institute
Michael J. Kelley, Duke University Medical Center/Durham VA Medical Center
Paul Kluetz, Food and Drug Administration
Karen E. Knudsen, American Cancer Society
Christopher Lathan, Dana-Farber Cancer Institute/Harvard Medical School
Inga T. Lennes, Massachusetts General Hospital
Douglas Lowy, National Cancer Institute
Michael McNeely, Health Resources and Services Administration
Fareed Melhem, Medidata Solutions
Marcella Nunez-Smith, Presidential COVID-19 Health Equity Task Force/Yale School of Medicine
Randall A. Oyer, Association of American Cancer Centers, Penn Medicine Lancaster General
Steven Pergam, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Jane Perlmutter, Patient Advocate
Lori Pierce, American Society of Clinical Oncology
Leonard Sacks, Food and Drug Administration
Bhuvana Sagar, Cigna Health Care
Lawrence Shulman, University of Pennsylvania Abramson Cancer Center
David Spigel, Sarah Cannon Research Institute
Lara Strawbridge, Center for Medicare & Medicaid Innovation
Karen M. Winkfield, Meharry-Vanderbilt Alliance
Robert A. Winn, VCU Massey Cancer Center
Robin Zon, Michiana Hematology Oncology
Planning Committee
Richard L. Schilsky (Chair), University of Chicago
Sundeep Argawal, Food and Drug Administration
Christina Chapman, University of Michigan
Nancy E. Davidson, Fred Hutchinson Cancer Research Center /Seattle Cancer Care Alliance
Melissa Dillmon, Harbin Clinic Cancer Center
James H. Doroshow, National Cancer Institute
Samir Khleif, Georgetown University
Karen Knudsen, American Cancer Society
Mia Levy, Rush University Medical Center
Larissa Nekhyludov, Harvard Medical School and Brigham & Women's Hospital
Randall A. Oyer, Association of Community Cancer Centers/ Penn Medicine Lancaster General
Antoni Ribas, University of California, Los Angeles/ American Association of Cancer Research
Donna Rivera, Food and Drug Administration
Lawrence N. Shulman, University of Pennsylvania Abramson Cancer Center
Robert A. Winn, Virginia Commonwealth University Massey Cancer Center